The prevalence of mild cognitive impairment in breast cancer patients receiving chemotherapy according to the criteria of the National Institute on Aging-Alzheimer ’s Association (NIA-AA)
ConclusionsTwenty percent of breast cancer patients treated with chemotherapy met NIA-AA criteria for MCI, compared with 7.6% of the controls.Implications for Cancer SurvivorsThese criteria, which include formal test performance as well as a person ’s symptoms and functional status, can be useful in clinical practice and scientific research.
Source: Journal of Cancer Survivorship - Category: Cancer & Oncology Source Type: research
More News: Alzheimer's | Brain | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Dementia | Education | Neurology | Neuroscience | Universities & Medical Training | Women